NCT02709525

Brief Summary

The aim of this study is to evaluate the effects of hyaluronic acid (HA) on bone healing in human dental sockets.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
16

participants targeted

Target at below P25 for phase_1

Timeline
Completed

Started Jul 2012

Typical duration for phase_1

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 1, 2012

Completed
3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2015

Completed
8 months until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2016

Completed
7 days until next milestone

First Submitted

Initial submission to the registry

March 8, 2016

Completed
8 days until next milestone

First Posted

Study publicly available on registry

March 16, 2016

Completed
Last Updated

March 16, 2016

Status Verified

March 1, 2016

Enrollment Period

3 years

First QC Date

March 8, 2016

Last Update Submit

March 15, 2016

Conditions

Keywords

hyaluronic acidbone repairdental socketcone beam computed tomography

Outcome Measures

Primary Outcomes (5)

  • Percentage of bone formation

    During the postoperative interval of 30 days, the patients underwent cone beam computed tomography (CBCT). Five central transverse scan images were captured from each socket. Using the KS300 software, the gray intensity was measured in each image and the results were expressed as mean percentage of bone formation

    30 days after extraction and treatment application

  • Fractal dimension

    During the postoperative interval of 30 days, the patients underwent cone beam computed tomography (CBCT). Five central transverse scan images were captured from each socket. The pattern of the alveolar trabecular bone was also evaluated through the fractal dimension in each image.

    30 days after extraction and treatment application

  • Dimensional Alveolar changes

    To determine whether treatment could prevent loss of buccolingual thickness, was compared bone loss of 90 to 30 days between the treated and control groups.

    30 to 90 days after extraction and treatment application

  • Percentage of bone formation

    During the postoperative interval of 90 days, the patients underwent cone beam computed tomography (CBCT). Five central transverse scan images were captured from each socket. Using the KS300 software, the gray intensity was measured in each image and the results were expressed as mean percentage of bone formation

    90 days after extraction and treatment application

  • Fractal dimension

    During the postoperative interval of 90 days, the patients underwent cone beam computed tomography (CBCT). Five central transverse scan images were captured from each socket. The pattern of the alveolar trabecular bone was also evaluated through the fractal dimension in each image.

    90 days after extraction and treatment application

Study Arms (2)

hyaluronic acid

EXPERIMENTAL

Immediately after the extractions, one socket was randomly filled with 1% hyaluronic acid gel.

Drug: hyaluronic acid

Blood clot

PLACEBO COMPARATOR

Immediately after the extractions, the other side socket was naturally filled with blood clot.

Other: Placebo

Interventions

Also known as: Hyaluronan, Sodium hyaluronate
hyaluronic acid
PlaceboOTHER
Blood clot

Eligibility Criteria

Age14 Years - 40 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • Orthodontic need for bilateral extraction of lower first premolars

You may not qualify if:

  • Alcoholism, smoking, drug use and abuse of drugs; Systemic diseases: uncontrolled diabetes, blood dyscrasias, kidney or heart failure and osteoporosis; clinical or radiographic signs of pathological processes in the bone;

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Alveolar Bone Loss

Interventions

Hyaluronic Acid

Condition Hierarchy (Ancestors)

Bone ResorptionBone DiseasesMusculoskeletal DiseasesPeriodontal AtrophyPeriodontal DiseasesMouth DiseasesStomatognathic Diseases

Intervention Hierarchy (Ancestors)

GlycosaminoglycansPolysaccharidesCarbohydrates

Study Officials

  • Anderson Ferreira, Professor

    Instituto de Ciências Biológicas - Universidade Federal de Minas Gerais

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
phase 1
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
MSc,PhD Student, Professor

Study Record Dates

First Submitted

March 8, 2016

First Posted

March 16, 2016

Study Start

July 1, 2012

Primary Completion

July 1, 2015

Study Completion

March 1, 2016

Last Updated

March 16, 2016

Record last verified: 2016-03